Answer
Oral disopyramide passes into breast milk; although no infant adverse effects have been noted, experience is limited, so use during breastfeeding should be considered essential by the clinician, with close infant supervision, particularly for anticholinergic effects, drug levels checked if necessary, and ideally alternative feeding.
Sources for this answer
- Rythmodan Retard 250mg Modified Release TabletsNeon Healthcare Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked